Nanomedicine strategies for management of drug resistance in lung cancer

M Haider, A Elsherbeny, V Pittalà, V Consoli… - International Journal of …, 2022 - mdpi.com
Lung cancer (LC) is one of the leading causes of cancer occurrence and mortality
worldwide. Treatment of patients with advanced and metastatic LC presents a significant …

Nanomedicine Combats Drug Resistance in Lung Cancer

X Zheng, X Song, G Zhu, D Pan, H Li, J Hu… - Advanced …, 2024 - Wiley Online Library
Lung cancer is the second most prevalent cancer and the leading cause of cancer‐related
death worldwide. Surgery, chemotherapy, molecular targeted therapy, immunotherapy, and …

Nanotechnology-based approaches overcome lung cancer drug resistance through diagnosis and treatment

J Li, L Zhu, HF Kwok - Drug Resistance Updates, 2023 - Elsevier
Lung cancer continues to be a malignant tumor with high mortality. Two obstacles interfere
with curative therapy of lung cancer:(i) poor diagnosis at the early stages, as symptoms are …

[HTML][HTML] Emerging nano-based strategies against drug resistance in tumor chemotherapy

L Cao, Y Zhu, W Wang, G Wang, S Zhang… - … in bioengineering and …, 2021 - frontiersin.org
Drug resistance is the most significant causes of cancer chemotherapy failure. Various
mechanisms of drug resistance include tumor heterogeneity, tumor microenvironment …

Emerging nanotechnology-based therapeutics to combat multidrug-resistant cancer

P Yadav, SV Ambudkar, N Rajendra Prasad - Journal of …, 2022 - Springer
Cancer often develops multidrug resistance (MDR) when cancer cells become resistant to
numerous structurally and functionally different chemotherapeutic agents. MDR is …

Role of nanotechnology in overcoming the multidrug resistance in cancer therapy: A review

SA Mir, L Hamid, GN Bader, A Shoaib, M Rahamathulla… - Molecules, 2022 - mdpi.com
Cancer is one of the leading causes of morbidity and mortality around the globe and is likely
to become the major cause of global death in the coming years. As per World Health …

Novel nanomedicines to overcome cancer multidrug resistance

Z Su, S Dong, SC Zhao, K Liu, Y Tan, X Jiang… - Drug Resistance …, 2021 - Elsevier
Chemotherapy remains a powerful tool to eliminate malignant cells. However, the efficacy of
chemotherapy is compromised by the frequent emergence of intrinsic and acquired …

Nanomedicines for combating multidrug resistance of cancer

YX Zhu, HR Jia, QY Duan, FG Wu - Wiley Interdisciplinary …, 2021 - Wiley Online Library
Chemotherapy typically involves the use of specific chemodrugs to inhibit the proliferation of
cancer cells, but the frequent emergence of a variety of multidrug‐resistant cancer cells …

[HTML][HTML] Nanomedicine therapeutic approaches to overcome cancer drug resistance

JL Markman, A Rekechenetskiy, E Holler… - Advanced drug delivery …, 2013 - Elsevier
Nanomedicine is an emerging form of therapy that focuses on alternative drug delivery and
improvement of the treatment efficacy while reducing detrimental side effects to normal …

Circumventing tumor resistance to chemotherapy by nanotechnology

XJ Liang, C Chen, Y Zhao, PC Wang - Multi-drug resistance in cancer, 2010 - Springer
Patient relapse and metastasis of malignant cells is very common after standard cancer
treatment with surgery, radiation, and/or chemotherapy. Chemotherapy, a cornerstone in the …